Active Ingredient(s): Taliglucerase Alfa
FDA Approved: * May 1, 2012
Pharm Company: * PROTALIX LTD
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Elelyso Overview

Taliglucerase alfa, sold under the brand name Elelyso among others, is a biopharmaceutical medication developed by Protalix and Pfizer.[1][2][full citation needed] The drug, a recombinant glucocerebrosidase used to treat Gaucher's disease, is the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration (FDA).[3][4] Each vial has 200 units of taliglucerase alfa. Contents 1 Approva...

Read more Elelyso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Taliglucerase_alfa

Recent Elelyso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Taliglucerase Alfa
  • Injection: 200 units/vial
  • Powder: 200 units/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Elelyso: (1 result)

Sorted by National Drug Code
  • 0069-0106 Elelyso 200 U/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc

Other drugs which contain Taliglucerase Alfa or a similar ingredient: (1 result)